Viewing StudyNCT04920708



Ignite Creation Date: 2024-05-06 @ 4:16 PM
Last Modification Date: 2024-10-26 @ 2:06 PM
Study NCT ID: NCT04920708
Status: RECRUITING
Last Update Posted: 2023-10-27
First Post: 2021-05-27

Brief Title: Fulvestrant Ipatasertib and CDK46 Inhibition in Metastatic ERHER2- Breast Cancer Patients Without ctDNA Suppression
Sponsor: Royal Marsden NHS Foundation Trust
Organization: Royal Marsden NHS Foundation Trust

Conditions & Keywords Data

Conditions:
Name
Metastatic Breast Cancer
ER Breast Cancer
Advanced Breast Cancer
Keywords:
Name View
ctDNA View
Fulvestrant View
Palbociclib View
Ipatasertib View